Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-CD30/TNFRSF8 Antibody-APC (9U146)
🥰Excellent
Catalog No. TMAY-01164A
Anti-CD30/TNFRSF8 Antibody-APC (9U146) is a APC-conjugated Rabbit antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9U146) can be used in FCM.
Anti-CD30/TNFRSF8 Antibody-APC (9U146)
Anti-CD30/TNFRSF8 Antibody-APC (9U146)
🥰Excellent
Catalog No. TMAY-01164A
Anti-CD30/TNFRSF8 Antibody-APC (9U146) is a APC-conjugated Rabbit antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9U146) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-CD30/TNFRSF8 Antibody-APC (9U146) is a APC-conjugated Rabbit antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9U146) can be used in FCM. |
| Ig Type | Monoclonal Rabbit IgG |
| Clone | 9U146 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human TNFRSF8(CD30) expression on K562 cells. Cells were stained with APC-conjugated anti-Human TNFRSF8(CD30). The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human CD30 / TNFRSF8 (rh CD30 / TNFRSF8; TMPY-01827; NP_001234.2; Met1-Lys379) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.09% sodium azide |
| Research Background | CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 protein is expressed by activated, but not resting, T and B cells. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication. As a regulator of apoptosis, CD30 protein induces cell death or proliferation, depending on the cell type, and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs), and CD30 is also linked to leukocytes in patients with chronic inflammatory diseases, including lupus erythematosus, asthma, rheumatoid arthritis and atopic dermatitis (AD).Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | APC |
| Others Formats | PE |
| Antibody Types Available | 2 |
| Immunogen | Recombinant Human CD30 / TNFRSF8 protein (TMPY-01827) |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-CD30/TNFRSF8 Antibody-APC (9U146) | purchase Anti-CD30/TNFRSF8 Antibody-APC (9U146) | Anti-CD30/TNFRSF8 Antibody-APC (9U146) cost | order Anti-CD30/TNFRSF8 Antibody-APC (9U146)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.